ceftobiprole: Clinical Trials

9 trials of ceftobiprole, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed, 2 terminated. 9 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 19Completed 7, Terminated 2

Follow ceftobiprole: new trials by email Literature Review of ceftobiprole trials Research Report on ceftobiprole

Trials (filtered) newest first · largest first

All 9 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Assess the Effect of Ceftobiprole on the PK of Pitavastatin and on Plasma Levels of Coproporphyrin
pitavastatin, pitavastatin single dose combined with ceftobiprole - Drug-drug Interaction Study
Phase 1CompletedBasilea Pharmaceutica122025-01-172026-04-21
Pharmacokinetics and Safety of Ceftobiprole in Neonates and Infants up to 3 Months Treated With Systemic Antibiotics
Ceftobiprole medocaril - Bacterial Infections
Phase 1TerminatedBasilea Pharmaceutica152016-11-222023-06-05
Effect of Ceftobiprole on Human Intestinal Microflora
Ceftobiprole - Antimicrobial Agent, Cephalosporins
Phase 1CompletedBasilea Pharmaceutica122009-04-012012-07-30
Pharmacokinetic Study of the Penetration of Ceftobiprole in the Bone
Ceftobiprole - Total Hip Replacement Surgery
Phase 1CompletedBasilea Pharmaceutica222009-04-012012-07-30
Open Label Pharmacokinetic in Adult Patients With Ventilator-Associated Pneumonia
Ceftobiprole - Ventilator Associated Pneumonia
Phase 1TerminatedBasilea Pharmaceutica12008-10-012012-07-30
A Single-Dose Pharmacokinetics and Safety Study of Ceftobiprole in Pediatric Patients =3 Months to <18 Years of Age
Ceftobiprole - Staphylococcal Skin Infections, Streptococcal Infections
Phase 1CompletedBasilea Pharmaceutica642007-08-012012-07-27
A Study Evaluating the Pharmacokinetics of Ceftobiprole When Taken by Obese Patients
Ceftobiprole - Obesity, Staphylococcal Skin Infections
Phase 1CompletedBasilea Pharmaceutica252007-08-012012-08-28
Evaluation of Penetration of Ceftobiprole Into Soft Tissue Determined by Microdialysis in Healthy Volunteers
Ceftobiprole - Staphylococcal Skin Infections, Streptococcal Infections
Phase 1CompletedBasilea Pharmaceutica152007-06-012012-07-30
Pharmacokinetic Study,Ceftobiprole,Healthy Volunteers,Healthy Patients With End Stage Renal Disease
Ceftobiprole - Staphylococcal Skin Infections, Streptococcal Infections
Phase 1CompletedBasilea Pharmaceutica122007-05-012012-08-28

Conditions studied

Staphylococcal Skin Infections (4)  ·  Streptococcal Infections (4)  ·  Cellulitis (2)  ·  Bacterial Infections (1)  ·  Obesity (1)  ·  Pneumonia, Ventilator-Associated (1)  ·  Soft Tissue Infections (1)

Sponsors

Basilea Pharmaceutica (9)

Countries

Belgium (1)  ·  Germany (1)  ·  Latvia (1)  ·  Lithuania (1)  ·  Netherlands (1)  ·  Poland (1)  ·  United States (1)

Top investigators

Marc Engelhardt, MD (1)  ·  Thomas Kaindl, MD (1)

Results publications

PMID 20926263, PMID 34533489